Shandong Lu Kang Pharmaceutical Co., Ltd. is one of the four major antibiotic production bases in China, and the first large-scale joint-stock enterprise in the pharmaceutical industry in Shandong Province. "Lu Kang Pharmaceutical" A shares were listed on the Shanghai Stock Exchange in February 1997, with the stock code of 6789.
Lu Kang pharmaceutical co., ltd. is a large-scale national first-class enterprise and the most complete variety of domestic pharmaceutical enterprises that have passed GMP certification, and it is the first enterprise in China to pass ISO91 quality system certification and ISO141 environmental system certification. "Lu Kang Brand" trademark was officially recognized as a well-known trademark in China by the Trademark Office of the State Administration for Industry and Commerce, and it is one of the five internationally renowned brands cultivated in Shandong Province. The company mainly produces and operates antibiotic raw materials, semi-synthetic antibiotic raw materials and related preparation products, pharmaceutical intermediates and so on. The company actively adjusted the product layout and optimized the product structure, and now it has formed three series of product chains with 6-APA, 7-ACA and 7-ADCA as the mother cores, realizing the successful leap from traditional antibiotic production to semi-synthetic antibiotic production. By December 31, 26, the company's total assets reached 2.43 billion yuan.
Lu Kang Company normally produces more than 1 kinds of drugs. The company has established internal control standards higher than those in the National Pharmacopoeia and implemented the "quality veto" system. Excellent quality, won the public's trust, all products of Lu Kang Pharmaceutical were rated as high-quality products at or above the provincial level, and the pass rate of product market spot check was 1% for 18 consecutive years.
the god of life ensures health. Based on the strategic goal of sustained and far-reaching development, Lu Kang Medicine holds high the green banner of the national pharmaceutical industry, gathers development momentum with scientific and technological innovation, management innovation and marketing innovation, takes modern biotechnology as a means, takes the protection of patients' lives as its own responsibility, and strives to serve the people's medical and health care!